Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loperamide vs placebo for ileostomy output (crossover study)
2014-004740-35Phase 4Terminated
- Sponsor
- University Hospital Odense
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of loperamide in autoimmune colitis, rectal cancer, short bowel syndrome (SBS) and 1 more (2 arms), sponsored by University Hospital Odense. Primary endpoint: Difference in weight of stoma output. Started Nov 2014; status: terminated.
02
Drugs
loperamide
03
Conditions
autoimmune colitisrectal cancershort bowel syndrome (SBS)diarrhea
Beyond the preview
Go deeper on 2014-004740-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004740-35.